Market Research Firm: July 2014

Wednesday 23 July 2014

Bifenthrin Market - Global Analysis and Industry Outlook, 2014-2020

Bifenthrin is a chemical compound used as an insecticide. Bifenthrin is a pyrethroid insecticide largely used against red imported fire ants. In addition, bifenthrin is effective against insects such as worms, aphids, ants, moths, gnats, grasshoppers, beetles, midges, mites, ticks, spiders, maggots, yellow jackets, caterpillars, thrips, flies and fleas. Bifenthrin is typically used in nurseries, orchards and homes. The global bifenthrin market is mainly driven by the agriculture sector across the world. The increasing need for better yield due to decreasing arable land and rapidly rising world population is anticipated to fuel the demand for insecticides across the globe. In the agricultural industry, bifenthrin is used extensively for the protection of crops such as corn. The growing demand from nurseries, orchards, homes and agriculture industry is expected to drive the global bifenthrin industry in the next few years.

Browse Full Report with TOC: http://www.transparencymarketresearch.com/bifenthrin-market.html

Bifenthrin is pale tan to off-white in color and can be crystalline, waxy solid or viscous liquid. Bifenthrin has a weak, aromatic odor. Insecticide products containing bifenthrin are used on cotton, cereals, corn, alfalfa, hay, specific fruits, grass seed, ornamentals, and vegetables. The rising demand in the cultivation such a wide range of plants is predicted to drive the global bifenthrin market in the next few years.

Asia Pacific is expected to be the fastest growing market for bifenthrinin the next six years. The main reason for this is the growing demand from emergent countries such as China, India and South East Asian countries such as Indonesia, Thailand, Vietnam and Malaysia. Additionally, the countries in the geographies such as Africa, South America and the Middle East are showing dynamic economic growth since the last few years. These nations largely include South Africa, Brazil, Argentina, Jordan, Saudi Arabia, Egypt and Israel. Moreover, the U.S. and the European economies are gradually recovering from the economic depression. All such economic, industrial and demographic factors are ultimately creating a positive prospect for the global economy. Considering this positive outlook, agriculture related industries are anticipated to record an astounding growth in the coming years.

There is an astonishing market potential for the pesticides industry in the countries such as China, India, Thailand, Indonesia, Vietnam and Brazil where the government is focusing on increasing the agriculture production to meet the growing demand from the rising population. Due to this, the demand for insecticides such as bifenthrinin in agriculture, nurseries and orchards is projected to grow at a noteworthy rate in the next few years. The major insecticides companies are focusing on these developing economies for tapping their enormous market potential. The key manufacturers of pesticides are installing robust production facilities in these growing countries to fulfill the increasing local demand. Therefore, the global bifenthrin market is expected to witness a significant growth in the near future.

Some of the major companies operating in the global bifenthrin market are American Vanguard Corporation, Bayer Cropscience AG, Syngenta AG, Arysta Lifescience Corporation, Chemtura Corporation, BASF SE, Cleary Chemical Corporation, Cheminova AS, Dow Chemical Company, Drexel Chemical Company, E.I. Dupont De Nemours and Company, Sabero Organics Gujarat Ltd., Hokko Chemical Industry Co. Ltd., Isagro SPA, FMC Corporation, Ishihara Sangyo Kaisha Ltd., Rallis India Ltd., Makhteshim Agan Industries, Kumiai Chemical Industry Co. Ltd., Mitsui Chemicals Inc., Monsanto Company, Nissan Chemical Industries Ltd., Nufarm Ltd., Nippon Soda Co. Ltd., Sumitomo Chemical Company Ltd., United Phosphorus Ltd. and Wilbur-Ellis Company among others.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends.

Geographies analyzed under this research report include

North America
Asia Pacific
Europe
Rest of the World

This report provides comprehensive analysis of

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

More Reports on Chemical & Materials Market: http://www.transparencymarketresearch.com/chemical-market-reports-2.html

About Us

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

Contact:

Transparency Market Research

90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Browse Market Research Blogs:

https://marketingfirmblog.wordpress.com

Hepatitis C Therapeutics Market - Global Industry Research Report, 2014-2020

Hepatitis is defined as the inflammation of the liver due to an infection by a virus or other causative organism or toxin. Hepatitis C on the other hand, is primarily as a result of the infection by hepatitis C virus (HCV). With a cure rate between 50%-80%, and no commercially available vaccine as of yet, hepatitis C is considered a deadly disease with a moderate to high infection rate. It is the leading cause for liver transplantation in the U.K and North America.

The transmission of this virus in a majority occurs from injectables drug abuse, as the virus can only be transmitted via blood-to-blood contact. The secondary transmission factors include tattooing, sexual contact, healthcare (blood transfusion, organ transplant) mishaps, and other rare unknown cases. HIV infected individuals and AIDS patients too are at a higher risk of infection. The diagnosis of Hepatitis C is also very tricky as there lays a risk of misdiagnosis as the virus can go undetected in a liver biopsy sample. Liver enzyme levels may remain normal for an infected person for years, in some cases an infected person may go as long as 30 years without showing any symptoms of infection.

PCR amplification of purified and centrifuged biopsy samples done at specified time intervals are the best proven method for near accurate diagnosis.

This process is done so as to remove any errors caused as a result of false negatives by antibody immunoassay testing. However since PCR testing is quite expensive, initial screening is usually done via immunoassay method, in addition, immunoassay also determines the viral load and thereby help identify the stage of infection between acute and chronic. The acute stage of disease can generally be cured in majority of the cases, in some cases spontaneous curing has also been observed. Complete cure rate cannot be a possibility as Hepatitis C virus has various strains and is found to be mutative in nature. Chronic cases are seen in a majority of infected individuals and are also curable in some cases, but again among the majority, liver cirrhosis is observed, which may then require liver transplantation. Transplantation requires to be done with continuous medication, as chances of reinfection are very high. Therapy for Hepatitis C is not definitive but is generally done with a combination of medicines, namely pegylated-interferon-alpha and ribavirin, which is an antiviral. Other medications include boceprevir, ledipasvir, telaprevir, sofosbuvir and the novel simeprevir and sovaldi. These are either given as an addition to ribavirin or as a replacement, depending upon the condition, contraindication, genotype of virus and patient history.

At present the cost of the antiviral and interferon market remains the biggest hurdle for the proliferation of Hepatitis C therapeutics market. The prices vary from few hundred dollars to hundreds of thousands of dollars for a single dose. Insurances companies generally do not cover the complete cost of drugs in standard covers, often individuals who have very high premium are the only ones able to afford the treatment. The ongoing research into vaccination may also provide as a restraint in the future, as preventive vaccination has always shown greater success versus therapeutics.

The market for Hepatitis C therapeutics remains in billions, with new combinations being patented every year, and each having their own market segment. They are at present one of the most sought after investment segment in the healthcare drugs industry. With entry of Asian players the prices too are bound to decrease, thereby potentially increasing therapeutics market. The North American market is the highest market by volume, followed by Europe, as in these regions reported cases are high in number, and so is the affordability of drugs.

The major cause for Hepatitis C transmission in developed nations is intravenous narcotic/psychedelic drug abuse, which is common in these regions. In developing markets of Asia and South America, the leading cause for transmission is healthcare exposure and their poor standards. This along with their population size make for a large market, however unavailability of affordable drugs is often the reason why markets haven’t been proliferated as of yet. However the recent growth of market in Asia Pacific is a positive sign for potential manufacturers. The rest of the world also follows a similar pattern.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include